- Haemophilus influenzae type b vaccination
- Hepatitis A vaccination
- Hepatitis B vaccination
- Human papillomavirus vaccination
- Influenza vaccination
- Measles, mumps, and rubella vaccination
- Meningococcal vaccination
- Pneumococcal vaccination
- Tetanus, diphtheria, and pertussis vaccination
- Varicella vaccination
- Zoster vaccination
Vaccines in the Adult Immunization Schedule
Vaccines | Abbreviations | Trade names |
---|---|---|
Haemophilus influenzae type b | Hib |
ActHIB® Hiberix® PedvaxHIB® |
Hepatitis A vaccine | HepA |
Havrix® Vaqta® |
Hepatitis A and hepatitis B vaccine | HepA-HepB | Twinrix® |
Hepatitis B vaccine | HepB |
Engerix-B® Recombivax HB® Heplisav-B® |
Human papillomavirus vaccine | HPV vaccine | Gardasil 9® |
Influenza vaccine, inactivated | IIV | Many brands |
Influenza vaccine, live, attenuated | LAIV4 | FluMist® Quadrivalent |
Influenza vaccine, recombinant | RIV4 | Flublok Quadrivalent® |
Measles, mumps, and rubella vaccine | MMR | M-M-R® II |
Meningococcal serogroups A, C, W, Y vaccine |
MenACWY-D MenACWY-CRM MenACWY-TT |
Menactra® Menveo® MenQuadfi® |
Meningococcal serogroup B vaccine |
MenB-4C MenB-FHbp |
Bexsero® Trumenba® |
Pneumococcal 13-valent conjugate vaccine | PCV13 | Prevnar 13® |
Pneumococcal 23-valent polysaccharide vaccine | PPSV23 | Pneumovax® 23 |
Tetanus and diphtheria toxoids | Td |
Tenivac® Tdvax™ |
Tetanus and diphtheria toxoids and acellular pertussis vaccine | Tdap |
Adacel® Boostrix® |
Varicella vaccine | VAR | Varivax® |
Zoster vaccine, recombinant | RZV | Shingrix |
This schedule is recommended by the Advisory Committee on Immunization Practices (ACIP) and approved by the Centers for Disease Control and Prevention (CDC), American College of Physicians (ACPexternal icon), American Academy of Family Physicians (AAFPexternal icon), American College of Obstetricians and Gynecologists (ACOGexternal icon), American College of Nurse-Midwives (ACNMexternal icon), and American Academy of Physician Assistants (AAPAexternal icon).
The comprehensive summary of the ACIP recommended changes made to the adult immunization schedule can be found in the February 12, 2021 MMWR.
Report
- Suspected cases of reportable vaccine-preventable diseases or outbreaks to the local or state health department
- Clinically significant postvaccination reactions to the Vaccine Adverse Event Reporting System or 800‑822‑7967
Injury Claims All vaccines included in the adult immunization schedule except pneumococcal 23-valent polysaccharide (PPSV23) and zoster (RZV) vaccines are covered by the Vaccine Injury Compensation Program. Information on how to file a vaccine injury claim is available at www.hrsa.gov/vaccinecompensation.
Questions or comments
Contact www.cdc.gov/cdc-info or 800-CDC-INFO (800-232-4636), in English or Spanish, 8 a.m.–8 p.m. ET, Monday through Friday, excluding holidays.
Helpful information
- Complete ACIP recommendations
- General Best Practice Guidelines for Immunization
(including contraindications and precautions) - Vaccine Information Statements
- Manual for the Surveillance of Vaccine-Preventable Diseases
(including case identification and outbreak response) - Travel vaccine recommendations
- ACIP Shared Clinical Decision-Making Recommendations